Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ruggedtextile
    Member
    • Nov 2011
    • 18

    Quantifying contamination in RNA-Seq

    I have some RNA-Seq data with a low proportion of reads aligning to the human genome (<50% in most samples, <20% in one or two). The sample prep involved very low numbers of human cells and so we are wondering if bacterial or fungal contamination could have occurred which may explain this.

    Does anyone know of a resource/technique whereby I could test for this contamination? At the moment I am downloading bacterial 16S ribosomal sequences from RDP to see if I can align reads to those, but I'm wondering if there isn't a better way.
  • bruce01
    Senior Member
    • Mar 2011
    • 160

    #2
    Have a look at FastQ Screen from Simon Andrews: http://seqanswers.com/forums/showthread.php?t=10288

    Comment

    • ruggedtextile
      Member
      • Nov 2011
      • 18

      #3
      Thanks! Looks good.

      Comment

      • bruce01
        Senior Member
        • Mar 2011
        • 160

        #4
        Yes it is! Just make sure you have all potential contaminants bowtie indexed.

        Comment

        • TonyBrooks
          Senior Member
          • Jun 2009
          • 303

          #5
          How did you prep your samples? If you only had a few cells to begin with, I'm assuming there's some kind of amplification process going on during library prep.
          Run your data through FASTQC. It should pick out any over-represented sequences (i.e. amplification primers).
          We've done low cell number RNA-Seq before with the SMARTer kit from Clontech. It's good but there's a large amount of primer in the sequencing. Getting rid of these sequences improves our alignment %'s massively.

          Comment

          • ruggedtextile
            Member
            • Nov 2011
            • 18

            #6
            We used the NuGen Ovation kit. I did see quite a bit of primer contamination (detected with FASTQC), but even after trimming that out with reaper I still see a very low alignment %. Still trying to work out where the rest of the reads are coming from...

            Comment

            • TonyBrooks
              Senior Member
              • Jun 2009
              • 303

              #7
              I take it you are aligning to the genome as you said and not transcriptome.
              We've had problems with DNA contamination when we tried NuGen preps. We had a lot of reads mapping to non-exonic sequences (due to the random priming).

              Comment

              • ruggedtextile
                Member
                • Nov 2011
                • 18

                #8
                Yes, aligning to the genome.

                I get poor levels of aligning (<50%) and then within the reads that do align very high levels of ribosomal, intergenic and intonic sequences, so in the end the fraction of usable reads for transcript estimation is too small.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  Yesterday, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  07-08-2026, 05:17 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, Yesterday, 11:10 AM
                0 responses
                9 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-13-2026, 10:26 AM
                0 responses
                30 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-09-2026, 10:04 AM
                0 responses
                41 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-08-2026, 10:08 AM
                0 responses
                26 views
                0 reactions
                Last Post SEQadmin2  
                Working...